1. Home
  2. ICL vs LNTH Comparison

ICL vs LNTH Comparison

Compare ICL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$5.18

Market Cap

6.3B

Sector

Industrials

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$66.53

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
LNTH
Founded
1968
1956
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
4.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ICL
LNTH
Price
$5.18
$66.53
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$6.23
$78.00
AVG Volume (30 Days)
934.6K
1.2M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
3.80%
N/A
EPS Growth
N/A
N/A
EPS
0.29
2.39
Revenue
$7,053,000,000.00
$1,525,933,000.00
Revenue This Year
$5.82
$0.01
Revenue Next Year
$5.42
$1.24
P/E Ratio
$17.77
$28.42
Revenue Growth
1.77
1.95
52 Week Low
$4.70
$47.25
52 Week High
$7.35
$111.29

Technical Indicators

Market Signals
Indicator
ICL
LNTH
Relative Strength Index (RSI) 45.13 64.46
Support Level $4.95 $64.13
Resistance Level $5.05 $68.84
Average True Range (ATR) 0.09 2.27
MACD 0.04 0.27
Stochastic Oscillator 79.21 74.42

Price Performance

Historical Comparison
ICL
LNTH

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: